Edwards Lifesciences Corp
Latest Filing: May 6, 2026 • 25 Total Filings
Total Assets
2026
$13.32B
Total Revenue
2026
$1.65B
Net Income
2026
$380.70M
Operating Cash Flow
2026
$43.80M

Error

Failed to load Risk Factors for EW